Cheol Ryong Ku

Clinical Associate Professor

Yonsei University College of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Cheol Ryong Ku is a Clinical Associate Professor at Yonsei University College of Medicine in South Korea. His research focuses on pituitary tumors, hyperprolactinemia, and the application of novel therapies for metabolic syndrome. Recent publications include studies on the localization of pituitary tumors using 68Ga-DOTATOC PET/CT and the role of circulating miR-20a-5p as a biomarker for cabergoline responsiveness. He is also investigating the potential of hydrogel-fiber-mesh-based 3D cell cultures and multiomics approaches for precision medicine in acromegaly.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

SOUTH KOREA

View details

Eui Hyun Kim

Yonsei University College of Medicine

SOUTH KOREA

View details

chan woo kang

Assistant Research Professor

Yonsei University Health System

SOUTH KOREA

View details

Sin Gon Kim

Korea University

SOUTH KOREA

View details

Sun Ho Kim

Yonsei University College of Medicine

SOUTH KOREA

View details

YuMin Kim

Gwangju Institute of Science and Technology

SOUTH KOREA

View details

Junhyung Kim

Assitant professor

Gangnam Severance Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cheol Ryong Ku

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Circulating miR-20a-5p as a biomarker associated with cabergoline responsiveness in patients with hyperprolactinemia and pituitary adenomas

68Ga-DOTATOC PET/CT in the Localization of Pituitary Tumors in Cushing’s Disease

Hydrogel-fiber-mesh-based 3D cell cultures: A new method for studying pituitary tumors

Highly functional duodenal stent with photosensitizers enables photodynamic therapy for metabolic syndrome treatment: Feasibility and safety study in a porcine model

Spliceosome component TCERG1 regulates the aggressiveness of somatotroph adenoma

Elucidating Clinical Queries for Tailored Therapy in Patients with Prolactinoma

Acetate-Mediated Odorant Receptor OR51E2 Activation Results in Calcitonin Secretion in Parafollicular C-Cells: A Novel Diagnostic Target of Human Medullary Thyroid Cancer

Sex differences in mortality in patients with acromegaly: a nationwide cohort study in Korea

Surgical Treatment of Prolactinomas: Potential Role as a First-Line Treatment Modality

Dexamethasone suppression for 18F-FDG PET/CT to localize ACTH-secreting pituitary tumors

Increased Risk of Hip Fracture in Patients with Acromegaly: A Nationwide Cohort Study in Korea

Surfactant-like photosensitizer for endoscopic duodenal ablation: Modulating meal-stimulated incretin hormones in obese and type 2 diabetes

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine

Olfactory marker protein regulation of glucagon secretion in hyperglycemia

Revisiting growth hormone nadir cut-offs for remission in patients with acromegaly

Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma

COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society

Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant

Radiomics With Ensemble Machine Learning Predicts Dopamine Agonist Response in Patients With Prolactinoma

Collaborators (12)

JaeHyung Koo

Namki Hong

Jung Hyun Jo

Myung-Han Yoon

Chang-Myung Oh

EUNKYUNG WANG

Eui Hyun Kim

chan woo kang

Sin Gon Kim

Sun Ho Kim

YuMin Kim

Junhyung Kim

Make your next move.